MD Anderson Cancer Center (Data Collection Only)

Houston, Texas 77030

7 studies enrolling now · 10 studies all time

What they study most

Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adult T-cell Leukemia/Lymphoma, Advanced Melanoma, Aggressive NK-cell Leukemia, Anaplastic Large Cell Lymphoma, ALK-Positive, Anaplastic Large Cell Lymphoma, ALK-negative, Angioimmunoblastic T-cell Lymphoma, Breast Implant-Associated Anaplastic Large Cell Lymphoma, Chondrosarcoma, Chondrosarcoma, Grade 2

Studies at this site

• A Registry for People With Lung Cancer — Recruiting now
• Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers — Recruiting now
• A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer — Recruiting now
• A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer — Recruiting now
• A Study of Revumenib and Mezigdomide in People With Leukemia — Recruiting now
• A Registry for People With T-cell Lymphoma — Recruiting now
• A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma — Recruiting now
• Humanized Monoclonal Antibody 3F8 (Hu3F8) With Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in the Treatment of Recurrent Osteosarcoma — Running, not enrolling
• AG-120 in People With IDH1 Mutant Chondrosarcoma — Running, not enrolling
• Study to Evaluate the Efficacy and Safety of Nintedanib (BIBF 1120) + Prednisone Taper in Patients With Radiation Pneumonitis — Completed